APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fractionated Plasma Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Fractionated Plasma Products Market Analysis and Forecast 2026-2032

2 January 2026206 pages

Choose your research edition.

Industry ResearchFractionated Plasma Products Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Fractionated Plasma Products Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Fractionated Plasma Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fractionated Plasma Products Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Fractionated Plasma Products Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Fractionated Plasma Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Fractionated Plasma Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Fractionated Plasma Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Fractionated Plasma Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Fractionated Plasma Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Fractionated Plasma Products include Takeda, Weiguang Bio, Tiantan Bio, Hualan Bio, Yuanda Shuyang, Shuanglin Bio, RAAS, Octapharma and Nanyue Bio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Fractionated Plasma Products, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Fractionated Plasma Products, also provides the revenue of main regions and countries. Of the upcoming market potential for Fractionated Plasma Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fractionated Plasma Products revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fractionated Plasma Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Fractionated Plasma Products revenue, projected growth trends, production technology, application and end-user industry.

Fractionated Plasma Products Segment by Company

Takeda

Weiguang Bio

Tiantan Bio

Hualan Bio

Yuanda Shuyang

Shuanglin Bio

RAAS

Octapharma

Nanyue Bio

LFB Group

KM Biologics

Kedrion

Grifols

CSL

CBPO

BPL

Boya Bio

Biotest

Fractionated Plasma Products Segment by Type

Coagulation Factor

Immune Globulin

Albumin

Other

Fractionated Plasma Products Segment by Application

Immunology

Hematology

Other

Fractionated Plasma Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fractionated Plasma Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fractionated Plasma Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fractionated Plasma Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Fractionated Plasma Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Fractionated Plasma Products company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fractionated Plasma Products revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Fractionated Plasma Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Coagulation Factor Major Player Table 3. Immune Globulin Major Player Table 4. Albumin Major Player Table 5. Other Major Player Table 6. Global Fractionated Plasma Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Immunology Major Player Table 8. Hematology Major Player Table 9. Other Major Player Table 10. Fractionated Plasma Products Industry Trends Table 11. Fractionated Plasma Products Industry Drivers Table 12. Fractionated Plasma Products Industry Opportunities and Challenges Table 13. Fractionated Plasma Products Industry Restraints Table 14. Global Fractionated Plasma Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Fractionated Plasma Products Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Fractionated Plasma Products Market Share by Region (2021-2026) Table 17. Global Fractionated Plasma Products Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Fractionated Plasma Products Market Share by Region (2027-2032) Table 19. Global Fractionated Plasma Products Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Fractionated Plasma Products Revenue Market Share by Players (2021-2026) Table 21. Global Fractionated Plasma Products Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Fractionated Plasma Products Key Players Headquarters & Area Served Table 23. Global Fractionated Plasma Products Players, Product Type & Application Table 24. Global Fractionated Plasma Products Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Fractionated Plasma Products by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Fractionated Plasma Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Fractionated Plasma Products Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Fractionated Plasma Products Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Fractionated Plasma Products Revenue Market Share by Type (2021-2026) Table 31. Global Fractionated Plasma Products Revenue Market Share by Type (2027-2032) Table 32. Global Fractionated Plasma Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Fractionated Plasma Products Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Fractionated Plasma Products Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Fractionated Plasma Products Revenue Market Share by Application (2021-2026) Table 36. Global Fractionated Plasma Products Revenue Market Share by Application (2027-2032) Table 37. Takeda Company Information Table 38. Takeda Business Overview Table 39. Takeda Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Takeda Fractionated Plasma Products Product Portfolio Table 41. Takeda Recent Development Table 42. Weiguang Bio Company Information Table 43. Weiguang Bio Business Overview Table 44. Weiguang Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Weiguang Bio Fractionated Plasma Products Product Portfolio Table 46. Weiguang Bio Recent Development Table 47. Tiantan Bio Company Information Table 48. Tiantan Bio Business Overview Table 49. Tiantan Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Tiantan Bio Fractionated Plasma Products Product Portfolio Table 51. Tiantan Bio Recent Development Table 52. Hualan Bio Company Information Table 53. Hualan Bio Business Overview Table 54. Hualan Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Hualan Bio Fractionated Plasma Products Product Portfolio Table 56. Hualan Bio Recent Development Table 57. Yuanda Shuyang Company Information Table 58. Yuanda Shuyang Business Overview Table 59. Yuanda Shuyang Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Yuanda Shuyang Fractionated Plasma Products Product Portfolio Table 61. Yuanda Shuyang Recent Development Table 62. Shuanglin Bio Company Information Table 63. Shuanglin Bio Business Overview Table 64. Shuanglin Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Shuanglin Bio Fractionated Plasma Products Product Portfolio Table 66. Shuanglin Bio Recent Development Table 67. RAAS Company Information Table 68. RAAS Business Overview Table 69. RAAS Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. RAAS Fractionated Plasma Products Product Portfolio Table 71. RAAS Recent Development Table 72. Octapharma Company Information Table 73. Octapharma Business Overview Table 74. Octapharma Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Octapharma Fractionated Plasma Products Product Portfolio Table 76. Octapharma Recent Development Table 77. Nanyue Bio Company Information Table 78. Nanyue Bio Business Overview Table 79. Nanyue Bio Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Nanyue Bio Fractionated Plasma Products Product Portfolio Table 81. Nanyue Bio Recent Development Table 82. LFB Group Company Information Table 83. LFB Group Business Overview Table 84. LFB Group Fractionated Plasma Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. LFB Group Fractionated Plasma Products Product Portfolio Table 86. LFB Group Recent Development Table 87. KM Biologics Company Information Table 88. KM Biologics Business Overview Table 89. KM Biologics Fractionated Plasma Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. KM Biologics Fractionated Plasma Products Product Portfolio Table 91. KM Biologics Recent Development Table 92. Kedrion Company Information Table 93. Kedrion Business Overview Table 94. Kedrion Fractionated Plasma Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Kedrion Fractionated Plasma Products Product Portfolio Table 96. Kedrion Recent Development Table 97. Grifols Company Information Table 98. Grifols Business Overview Table 99. Grifols Fractionated Plasma Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Grifols Fractionated Plasma Products Product Portfolio Table 101. Grifols Recent Development Table 102. CSL Company Information Table 103. CSL Business Overview Table 104. CSL Fractionated Plasma Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. CSL Fractionated Plasma Products Product Portfolio Table 106. CSL Recent Development Table 107. CBPO Company Information Table 108. CBPO Business Overview Table 109. CBPO Fractionated Plasma Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. CBPO Fractionated Plasma Products Product Portfolio Table 111. CBPO Recent Development Table 112. BPL Company Information Table 113. BPL Business Overview Table 114. BPL Fractionated Plasma Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. BPL Fractionated Plasma Products Product Portfolio Table 116. BPL Recent Development Table 117. Boya Bio Company Information Table 118. Boya Bio Business Overview Table 119. Boya Bio Fractionated Plasma Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Boya Bio Fractionated Plasma Products Product Portfolio Table 121. Boya Bio Recent Development Table 122. Biotest Company Information Table 123. Biotest Business Overview Table 124. Biotest Fractionated Plasma Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Biotest Fractionated Plasma Products Product Portfolio Table 126. Biotest Recent Development Table 127. North America Fractionated Plasma Products Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Fractionated Plasma Products Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Fractionated Plasma Products Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Fractionated Plasma Products Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Fractionated Plasma Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Fractionated Plasma Products Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Fractionated Plasma Products Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Fractionated Plasma Products Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Fractionated Plasma Products Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Fractionated Plasma Products Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Fractionated Plasma Products Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Fractionated Plasma Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Fractionated Plasma Products Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Fractionated Plasma Products Revenue by Country (US$ Million) & (2027-2032) Table 141. China Fractionated Plasma Products Revenue by Type (2021-2026) & (US$ Million) Table 142. China Fractionated Plasma Products Revenue by Type (2027-2032) & (US$ Million) Table 143. China Fractionated Plasma Products Revenue by Application (2021-2026) & (US$ Million) Table 144. China Fractionated Plasma Products Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Fractionated Plasma Products Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Fractionated Plasma Products Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Fractionated Plasma Products Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Fractionated Plasma Products Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Fractionated Plasma Products Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Fractionated Plasma Products Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Fractionated Plasma Products Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Fractionated Plasma Products Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Fractionated Plasma Products Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Fractionated Plasma Products Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Fractionated Plasma Products Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Fractionated Plasma Products Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Fractionated Plasma Products Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Fractionated Plasma Products Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Fractionated Plasma Products Image Figure 2. Global Fractionated Plasma Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fractionated Plasma Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Coagulation Factor Image Figure 5. Immune Globulin Image Figure 6. Albumin Image Figure 7. Other Image Figure 8. Global Fractionated Plasma Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Fractionated Plasma Products Market Size Share 2021 VS 2025 VS 2032 Figure 10. Immunology Image Figure 11. Hematology Image Figure 12. Other Image Figure 13. Global Fractionated Plasma Products Market Size (US$ Million) & (2021-2032) Figure 14. Global Fractionated Plasma Products Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Fractionated Plasma Products Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Fractionated Plasma Products Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Fractionated Plasma Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Fractionated Plasma Products Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Fractionated Plasma Products Revenue Market Share by Type (2021-2032) Figure 21. Global Fractionated Plasma Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Fractionated Plasma Products Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Fractionated Plasma Products Revenue Market Share by Application (2021-2032) Figure 24. North America Fractionated Plasma Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Fractionated Plasma Products Revenue Share by Type (2021-2032) Figure 26. North America Fractionated Plasma Products Revenue Share by Application (2021-2032) Figure 27. North America Fractionated Plasma Products Revenue Share by Country (2021-2032) Figure 28. United States Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Fractionated Plasma Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Fractionated Plasma Products Revenue Share by Type (2021-2032) Figure 33. Europe Fractionated Plasma Products Revenue Share by Application (2021-2032) Figure 34. Europe Fractionated Plasma Products Revenue Share by Country (2021-2032) Figure 35. Germany Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Fractionated Plasma Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Fractionated Plasma Products Revenue Share by Type (2021-2032) Figure 45. China Fractionated Plasma Products Revenue Share by Application (2021-2032) Figure 46. Asia Fractionated Plasma Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Fractionated Plasma Products Revenue Share by Type (2021-2032) Figure 48. Asia Fractionated Plasma Products Revenue Share by Application (2021-2032) Figure 49. Asia Fractionated Plasma Products Revenue Share by Region (2021-2032) Figure 50. Japan Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Fractionated Plasma Products Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Fractionated Plasma Products Revenue Share by Type (2021-2032) Figure 58. SAMEA Fractionated Plasma Products Revenue Share by Application (2021-2032) Figure 59. SAMEA Fractionated Plasma Products Revenue Share by Country (2021-2032) Figure 60. Brazil Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Fractionated Plasma Products Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Coagulation Factor
  • Immune Globulin
  • Albumin
  • Other
Applications
  • Immunology
  • Hematology
  • Other
Companies covered
  • Takeda
  • Weiguang Bio
  • Tiantan Bio
  • Hualan Bio
  • Yuanda Shuyang
  • Shuanglin Bio
  • RAAS
  • Octapharma
  • Nanyue Bio
  • LFB Group
  • KM Biologics
  • Kedrion
  • Grifols
  • CSL
  • CBPO
  • BPL
  • Boya Bio
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Fractionated Plasma Products Market by Type
  3. 1.2.1 Global Fractionated Plasma Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Coagulation Factor
  5. 1.2.3 Immune Globulin
  6. 1.2.4 Albumin
  7. 1.2.5 Other
  8. 1.3 Fractionated Plasma Products Market by Application
  9. 1.3.1 Global Fractionated Plasma Products Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Immunology
  11. 1.3.3 Hematology
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Fractionated Plasma Products Market Dynamics
  1. 2.1 Fractionated Plasma Products Industry Trends
  2. 2.2 Fractionated Plasma Products Industry Drivers
  3. 2.3 Fractionated Plasma Products Industry Opportunities and Challenges
  4. 2.4 Fractionated Plasma Products Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Fractionated Plasma Products Market Perspective (2021-2032)
  2. 3.2 Global Fractionated Plasma Products Growth Trends by Region
  3. 3.2.1 Global Fractionated Plasma Products Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Fractionated Plasma Products Market Size by Region (2021-2026)
  5. 3.2.3 Global Fractionated Plasma Products Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Fractionated Plasma Products Revenue by Players
  2. 4.1.1 Global Fractionated Plasma Products Revenue by Players (2021-2026)
  3. 4.1.2 Global Fractionated Plasma Products Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Fractionated Plasma Products Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Fractionated Plasma Products Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Fractionated Plasma Products Key Players Headquarters & Area Served
  7. 4.4 Global Fractionated Plasma Products Players, Product Type & Application
  8. 4.5 Global Fractionated Plasma Products Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Fractionated Plasma Products Market CR5 and HHI
  11. 4.6.3 2025 Fractionated Plasma Products Tier 1, Tier 2, and Tier 3
5 Fractionated Plasma Products Market Size by Type
  1. 5.1 Global Fractionated Plasma Products Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Fractionated Plasma Products Revenue by Type (2021-2032)
  3. 5.3 Global Fractionated Plasma Products Revenue Market Share by Type (2021-2032)
6 Fractionated Plasma Products Market Size by Application
  1. 6.1 Global Fractionated Plasma Products Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Fractionated Plasma Products Revenue by Application (2021-2032)
  3. 6.3 Global Fractionated Plasma Products Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Fractionated Plasma Products Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Weiguang Bio
  8. 7.2.1 Weiguang Bio Company Information
  9. 7.2.2 Weiguang Bio Business Overview
  10. 7.2.3 Weiguang Bio Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Weiguang Bio Fractionated Plasma Products Product Portfolio
  12. 7.2.5 Weiguang Bio Recent Developments
  13. 7.3 Tiantan Bio
  14. 7.3.1 Tiantan Bio Company Information
  15. 7.3.2 Tiantan Bio Business Overview
  16. 7.3.3 Tiantan Bio Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Tiantan Bio Fractionated Plasma Products Product Portfolio
  18. 7.3.5 Tiantan Bio Recent Developments
  19. 7.4 Hualan Bio
  20. 7.4.1 Hualan Bio Company Information
  21. 7.4.2 Hualan Bio Business Overview
  22. 7.4.3 Hualan Bio Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Hualan Bio Fractionated Plasma Products Product Portfolio
  24. 7.4.5 Hualan Bio Recent Developments
  25. 7.5 Yuanda Shuyang
  26. 7.5.1 Yuanda Shuyang Company Information
  27. 7.5.2 Yuanda Shuyang Business Overview
  28. 7.5.3 Yuanda Shuyang Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Yuanda Shuyang Fractionated Plasma Products Product Portfolio
  30. 7.5.5 Yuanda Shuyang Recent Developments
  31. 7.6 Shuanglin Bio
  32. 7.6.1 Shuanglin Bio Company Information
  33. 7.6.2 Shuanglin Bio Business Overview
  34. 7.6.3 Shuanglin Bio Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shuanglin Bio Fractionated Plasma Products Product Portfolio
  36. 7.6.5 Shuanglin Bio Recent Developments
  37. 7.7 RAAS
  38. 7.7.1 RAAS Company Information
  39. 7.7.2 RAAS Business Overview
  40. 7.7.3 RAAS Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  41. 7.7.4 RAAS Fractionated Plasma Products Product Portfolio
  42. 7.7.5 RAAS Recent Developments
  43. 7.8 Octapharma
  44. 7.8.1 Octapharma Company Information
  45. 7.8.2 Octapharma Business Overview
  46. 7.8.3 Octapharma Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Octapharma Fractionated Plasma Products Product Portfolio
  48. 7.8.5 Octapharma Recent Developments
  49. 7.9 Nanyue Bio
  50. 7.9.1 Nanyue Bio Company Information
  51. 7.9.2 Nanyue Bio Business Overview
  52. 7.9.3 Nanyue Bio Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Nanyue Bio Fractionated Plasma Products Product Portfolio
  54. 7.9.5 Nanyue Bio Recent Developments
  55. 7.10 LFB Group
  56. 7.10.1 LFB Group Company Information
  57. 7.10.2 LFB Group Business Overview
  58. 7.10.3 LFB Group Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  59. 7.10.4 LFB Group Fractionated Plasma Products Product Portfolio
  60. 7.10.5 LFB Group Recent Developments
  61. 7.11 KM Biologics
  62. 7.11.1 KM Biologics Company Information
  63. 7.11.2 KM Biologics Business Overview
  64. 7.11.3 KM Biologics Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  65. 7.11.4 KM Biologics Fractionated Plasma Products Product Portfolio
  66. 7.11.5 KM Biologics Recent Developments
  67. 7.12 Kedrion
  68. 7.12.1 Kedrion Company Information
  69. 7.12.2 Kedrion Business Overview
  70. 7.12.3 Kedrion Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Kedrion Fractionated Plasma Products Product Portfolio
  72. 7.12.5 Kedrion Recent Developments
  73. 7.13 Grifols
  74. 7.13.1 Grifols Company Information
  75. 7.13.2 Grifols Business Overview
  76. 7.13.3 Grifols Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Grifols Fractionated Plasma Products Product Portfolio
  78. 7.13.5 Grifols Recent Developments
  79. 7.14 CSL
  80. 7.14.1 CSL Company Information
  81. 7.14.2 CSL Business Overview
  82. 7.14.3 CSL Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CSL Fractionated Plasma Products Product Portfolio
  84. 7.14.5 CSL Recent Developments
  85. 7.15 CBPO
  86. 7.15.1 CBPO Company Information
  87. 7.15.2 CBPO Business Overview
  88. 7.15.3 CBPO Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CBPO Fractionated Plasma Products Product Portfolio
  90. 7.15.5 CBPO Recent Developments
  91. 7.16 BPL
  92. 7.16.1 BPL Company Information
  93. 7.16.2 BPL Business Overview
  94. 7.16.3 BPL Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  95. 7.16.4 BPL Fractionated Plasma Products Product Portfolio
  96. 7.16.5 BPL Recent Developments
  97. 7.17 Boya Bio
  98. 7.17.1 Boya Bio Company Information
  99. 7.17.2 Boya Bio Business Overview
  100. 7.17.3 Boya Bio Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Boya Bio Fractionated Plasma Products Product Portfolio
  102. 7.17.5 Boya Bio Recent Developments
  103. 7.18 Biotest
  104. 7.18.1 Biotest Company Information
  105. 7.18.2 Biotest Business Overview
  106. 7.18.3 Biotest Fractionated Plasma Products Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Biotest Fractionated Plasma Products Product Portfolio
  108. 7.18.5 Biotest Recent Developments
8 North America
  1. 8.1 North America Fractionated Plasma Products Revenue (2021-2032)
  2. 8.2 North America Fractionated Plasma Products Revenue by Type (2021-2032)
  3. 8.2.1 North America Fractionated Plasma Products Revenue by Type (2021-2026)
  4. 8.2.2 North America Fractionated Plasma Products Revenue by Type (2027-2032)
  5. 8.3 North America Fractionated Plasma Products Revenue Share by Type (2021-2032)
  6. 8.4 North America Fractionated Plasma Products Revenue by Application (2021-2032)
  7. 8.4.1 North America Fractionated Plasma Products Revenue by Application (2021-2026)
  8. 8.4.2 North America Fractionated Plasma Products Revenue by Application (2027-2032)
  9. 8.5 North America Fractionated Plasma Products Revenue Share by Application (2021-2032)
  10. 8.6 North America Fractionated Plasma Products Revenue by Country
  11. 8.6.1 North America Fractionated Plasma Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Fractionated Plasma Products Revenue by Country (2021-2026)
  13. 8.6.3 North America Fractionated Plasma Products Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Fractionated Plasma Products Revenue (2021-2032)
  2. 9.2 Europe Fractionated Plasma Products Revenue by Type (2021-2032)
  3. 9.2.1 Europe Fractionated Plasma Products Revenue by Type (2021-2026)
  4. 9.2.2 Europe Fractionated Plasma Products Revenue by Type (2027-2032)
  5. 9.3 Europe Fractionated Plasma Products Revenue Share by Type (2021-2032)
  6. 9.4 Europe Fractionated Plasma Products Revenue by Application (2021-2032)
  7. 9.4.1 Europe Fractionated Plasma Products Revenue by Application (2021-2026)
  8. 9.4.2 Europe Fractionated Plasma Products Revenue by Application (2027-2032)
  9. 9.5 Europe Fractionated Plasma Products Revenue Share by Application (2021-2032)
  10. 9.6 Europe Fractionated Plasma Products Revenue by Country
  11. 9.6.1 Europe Fractionated Plasma Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Fractionated Plasma Products Revenue by Country (2021-2026)
  13. 9.6.3 Europe Fractionated Plasma Products Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Fractionated Plasma Products Revenue (2021-2032)
  2. 10.2 China Fractionated Plasma Products Revenue by Type (2021-2032)
  3. 10.2.1 China Fractionated Plasma Products Revenue by Type (2021-2026)
  4. 10.2.2 China Fractionated Plasma Products Revenue by Type (2027-2032)
  5. 10.3 China Fractionated Plasma Products Revenue Share by Type (2021-2032)
  6. 10.4 China Fractionated Plasma Products Revenue by Application (2021-2032)
  7. 10.4.1 China Fractionated Plasma Products Revenue by Application (2021-2026)
  8. 10.4.2 China Fractionated Plasma Products Revenue by Application (2027-2032)
  9. 10.5 China Fractionated Plasma Products Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Fractionated Plasma Products Revenue (2021-2032)
  2. 11.2 Asia Fractionated Plasma Products Revenue by Type (2021-2032)
  3. 11.2.1 Asia Fractionated Plasma Products Revenue by Type (2021-2026)
  4. 11.2.2 Asia Fractionated Plasma Products Revenue by Type (2027-2032)
  5. 11.3 Asia Fractionated Plasma Products Revenue Share by Type (2021-2032)
  6. 11.4 Asia Fractionated Plasma Products Revenue by Application (2021-2032)
  7. 11.4.1 Asia Fractionated Plasma Products Revenue by Application (2021-2026)
  8. 11.4.2 Asia Fractionated Plasma Products Revenue by Application (2027-2032)
  9. 11.5 Asia Fractionated Plasma Products Revenue Share by Application (2021-2032)
  10. 11.6 Asia Fractionated Plasma Products Revenue by Country
  11. 11.6.1 Asia Fractionated Plasma Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Fractionated Plasma Products Revenue by Country (2021-2026)
  13. 11.6.3 Asia Fractionated Plasma Products Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Fractionated Plasma Products Revenue (2021-2032)
  2. 12.2 SAMEA Fractionated Plasma Products Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Fractionated Plasma Products Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Fractionated Plasma Products Revenue by Type (2027-2032)
  5. 12.3 SAMEA Fractionated Plasma Products Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Fractionated Plasma Products Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Fractionated Plasma Products Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Fractionated Plasma Products Revenue by Application (2027-2032)
  9. 12.5 SAMEA Fractionated Plasma Products Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Fractionated Plasma Products Revenue by Country
  11. 12.6.1 SAMEA Fractionated Plasma Products Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Fractionated Plasma Products Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Fractionated Plasma Products Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst